Functional role of NF-κB in expression of human endothelial nitric oxide synthase

Kyu Sun Lee, Joohwan Kim, Su Nam Kwak, Kwang Soon Lee, Dong Keon Lee, Kwon Soo Ha, Moo Ho Won, Dooil Jeoung, Hansoo Lee, Young-Guen Kwon, Young Myeong Kim

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The transcription factor NF-κB has an essential role in inflammation in endothelial cells. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) prevents vascular inflammation. However, the molecular mechanism underlying NF-κB-mediated regulation of eNOS expression has not been clearly elucidated. We here found that NF-κB-activating stimuli, such as lipopolysaccharide, tumor necrosis factor-α (TNF-α), and interleukin-1β, suppressed eNOS mRNA and protein levels by decreasing mRNA stability, without affecting promoter activity. TNF-α-mediated suppression of eNOS expression, mRNA stability, and 3′-untranslated region (3′UTR) activity were inhibited by NF-κB inhibitors and Dicer knockdown, but not by p38 MAPK and MEK inhibitors, suggesting the involvement of NF-κB-responsive miRNAs in eNOS expression. Moreover, TNF-α increased MIR155HG expression and promoter activity as well as miR-155 biogenesis, and these increases were blocked by NF-κB inhibitors. Transfection with antagomiR-155 blocked TNF-α-mediated suppression of eNOS 3′UTR activity, eNOS mRNA and protein levels, and NO and cGMP production. These data provide evidence that NF-κB is a negative regulator of eNOS expression via upregulation of miR-155 under inflammatory conditions. These results suggest that NF-κB is a potential therapeutic target for preventing vascular inflammation and endothelial dysfunction induced by suppression of miR-155-mediated eNOS expression.

Original languageEnglish
Pages (from-to)101-107
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume448
Issue number1
DOIs
Publication statusPublished - 2014 May 23

Fingerprint

Nitric Oxide Synthase Type III
Tumor Necrosis Factor-alpha
Messenger RNA
RNA Stability
3' Untranslated Regions
Inflammation
Blood Vessels
Nitric Oxide
Mitogen-Activated Protein Kinase Kinases
Endothelial cells
p38 Mitogen-Activated Protein Kinases
MicroRNAs
Interleukin-1
Transfection
Lipopolysaccharides
Proteins
Transcription Factors
Up-Regulation
Endothelial Cells

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lee, Kyu Sun ; Kim, Joohwan ; Kwak, Su Nam ; Lee, Kwang Soon ; Lee, Dong Keon ; Ha, Kwon Soo ; Won, Moo Ho ; Jeoung, Dooil ; Lee, Hansoo ; Kwon, Young-Guen ; Kim, Young Myeong. / Functional role of NF-κB in expression of human endothelial nitric oxide synthase. In: Biochemical and Biophysical Research Communications. 2014 ; Vol. 448, No. 1. pp. 101-107.
@article{0b7ef4492ed243fcaddfb2bc9c5ab963,
title = "Functional role of NF-κB in expression of human endothelial nitric oxide synthase",
abstract = "The transcription factor NF-κB has an essential role in inflammation in endothelial cells. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) prevents vascular inflammation. However, the molecular mechanism underlying NF-κB-mediated regulation of eNOS expression has not been clearly elucidated. We here found that NF-κB-activating stimuli, such as lipopolysaccharide, tumor necrosis factor-α (TNF-α), and interleukin-1β, suppressed eNOS mRNA and protein levels by decreasing mRNA stability, without affecting promoter activity. TNF-α-mediated suppression of eNOS expression, mRNA stability, and 3′-untranslated region (3′UTR) activity were inhibited by NF-κB inhibitors and Dicer knockdown, but not by p38 MAPK and MEK inhibitors, suggesting the involvement of NF-κB-responsive miRNAs in eNOS expression. Moreover, TNF-α increased MIR155HG expression and promoter activity as well as miR-155 biogenesis, and these increases were blocked by NF-κB inhibitors. Transfection with antagomiR-155 blocked TNF-α-mediated suppression of eNOS 3′UTR activity, eNOS mRNA and protein levels, and NO and cGMP production. These data provide evidence that NF-κB is a negative regulator of eNOS expression via upregulation of miR-155 under inflammatory conditions. These results suggest that NF-κB is a potential therapeutic target for preventing vascular inflammation and endothelial dysfunction induced by suppression of miR-155-mediated eNOS expression.",
author = "Lee, {Kyu Sun} and Joohwan Kim and Kwak, {Su Nam} and Lee, {Kwang Soon} and Lee, {Dong Keon} and Ha, {Kwon Soo} and Won, {Moo Ho} and Dooil Jeoung and Hansoo Lee and Young-Guen Kwon and Kim, {Young Myeong}",
year = "2014",
month = "5",
day = "23",
doi = "10.1016/j.bbrc.2014.04.079",
language = "English",
volume = "448",
pages = "101--107",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

Lee, KS, Kim, J, Kwak, SN, Lee, KS, Lee, DK, Ha, KS, Won, MH, Jeoung, D, Lee, H, Kwon, Y-G & Kim, YM 2014, 'Functional role of NF-κB in expression of human endothelial nitric oxide synthase', Biochemical and Biophysical Research Communications, vol. 448, no. 1, pp. 101-107. https://doi.org/10.1016/j.bbrc.2014.04.079

Functional role of NF-κB in expression of human endothelial nitric oxide synthase. / Lee, Kyu Sun; Kim, Joohwan; Kwak, Su Nam; Lee, Kwang Soon; Lee, Dong Keon; Ha, Kwon Soo; Won, Moo Ho; Jeoung, Dooil; Lee, Hansoo; Kwon, Young-Guen; Kim, Young Myeong.

In: Biochemical and Biophysical Research Communications, Vol. 448, No. 1, 23.05.2014, p. 101-107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Functional role of NF-κB in expression of human endothelial nitric oxide synthase

AU - Lee, Kyu Sun

AU - Kim, Joohwan

AU - Kwak, Su Nam

AU - Lee, Kwang Soon

AU - Lee, Dong Keon

AU - Ha, Kwon Soo

AU - Won, Moo Ho

AU - Jeoung, Dooil

AU - Lee, Hansoo

AU - Kwon, Young-Guen

AU - Kim, Young Myeong

PY - 2014/5/23

Y1 - 2014/5/23

N2 - The transcription factor NF-κB has an essential role in inflammation in endothelial cells. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) prevents vascular inflammation. However, the molecular mechanism underlying NF-κB-mediated regulation of eNOS expression has not been clearly elucidated. We here found that NF-κB-activating stimuli, such as lipopolysaccharide, tumor necrosis factor-α (TNF-α), and interleukin-1β, suppressed eNOS mRNA and protein levels by decreasing mRNA stability, without affecting promoter activity. TNF-α-mediated suppression of eNOS expression, mRNA stability, and 3′-untranslated region (3′UTR) activity were inhibited by NF-κB inhibitors and Dicer knockdown, but not by p38 MAPK and MEK inhibitors, suggesting the involvement of NF-κB-responsive miRNAs in eNOS expression. Moreover, TNF-α increased MIR155HG expression and promoter activity as well as miR-155 biogenesis, and these increases were blocked by NF-κB inhibitors. Transfection with antagomiR-155 blocked TNF-α-mediated suppression of eNOS 3′UTR activity, eNOS mRNA and protein levels, and NO and cGMP production. These data provide evidence that NF-κB is a negative regulator of eNOS expression via upregulation of miR-155 under inflammatory conditions. These results suggest that NF-κB is a potential therapeutic target for preventing vascular inflammation and endothelial dysfunction induced by suppression of miR-155-mediated eNOS expression.

AB - The transcription factor NF-κB has an essential role in inflammation in endothelial cells. Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) prevents vascular inflammation. However, the molecular mechanism underlying NF-κB-mediated regulation of eNOS expression has not been clearly elucidated. We here found that NF-κB-activating stimuli, such as lipopolysaccharide, tumor necrosis factor-α (TNF-α), and interleukin-1β, suppressed eNOS mRNA and protein levels by decreasing mRNA stability, without affecting promoter activity. TNF-α-mediated suppression of eNOS expression, mRNA stability, and 3′-untranslated region (3′UTR) activity were inhibited by NF-κB inhibitors and Dicer knockdown, but not by p38 MAPK and MEK inhibitors, suggesting the involvement of NF-κB-responsive miRNAs in eNOS expression. Moreover, TNF-α increased MIR155HG expression and promoter activity as well as miR-155 biogenesis, and these increases were blocked by NF-κB inhibitors. Transfection with antagomiR-155 blocked TNF-α-mediated suppression of eNOS 3′UTR activity, eNOS mRNA and protein levels, and NO and cGMP production. These data provide evidence that NF-κB is a negative regulator of eNOS expression via upregulation of miR-155 under inflammatory conditions. These results suggest that NF-κB is a potential therapeutic target for preventing vascular inflammation and endothelial dysfunction induced by suppression of miR-155-mediated eNOS expression.

UR - http://www.scopus.com/inward/record.url?scp=84901188380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901188380&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2014.04.079

DO - 10.1016/j.bbrc.2014.04.079

M3 - Article

VL - 448

SP - 101

EP - 107

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -